Homogeneous control specimens for estrogen receptor (ER) and progesterone receptor (PR) assays were prepared from freshly collected human uterus. After removal of the connective tissue, the specimen was washed with isotonic saline, cut into small pieces, quickly frozen in liquid nitrogen, and stored at -70 #{176}C until analyzed. Cytosol prepared from this specimen was lyophilized and stored at -70 #{176}C. A single step of reconstitution, with glycerol (100 mL/L) in water, is sufficient to prepare a control. Two specimens prepared this way were found to be reasonably stable for 20 months (first specimen, mean ± SD: ER = 22.1 ± 2.9 fmol/mg, PR = 136.5 ± 26.9 fmol/mg; second specimen: ER = 107.2 ± 11.7 fmol/mg, PR = 922 ± 71.6 fmol/mg). Another specimen, prepared similarly but not frozen in liquid nitrogen soon after collection, was less stable; its ER and PR concentrations deteriorated faster.
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In recent years, the presence of estrogen receptors (ER)'
and progesterone receptors (PR) in cancerous breast tumors has been shown to correlate well with response to endocrine therapy (1-3). As a result, these receptors in all surgically resected breast cancers are routinely measured at all major institutions (4-6).
The methods commonly used for measurement of these receptors include: sucrose density-gradient ultracentrifugation, adsorption on dextran-coated charcoal, single saturation-dose analysis (7) , gel filtration, electrophoresis (2), and histochemical methods (8) .
We have been quantifying ER and PR in breast tumors since 1976, using successively sucrose density-gradient ultracentrifugation, dextran-coated charcoal, and single saturation-dose analysis. Although these methods have been well established, each needs a control specimen to validate the ER and PR assays. Because no commercial control was available, we looked into the possibility of preparing our own control material from freshly collected human uterus. This article describes the preparation and stability of ER and PR in human uterus tissue. 
MaterIals and Methods
Preparation of the Control
Protein determination.
An aliquot of the cytosol was serially diluted in the buffer and the protein concentration was determined spectrophotometrically (9) . First, the volume of cytosol was adjusted to approximately 2.5 g/L with the buffer and its protein content was determined by the method of Lowry et a!. (10) . After making several dilutions of the cytosol, to obtain more accurate determination of protein concentration, the cytosol volume was then adjusted to exactly 2 g/L in the buffer. A few milligrams of sodium azide was added and 2-mL fractions were aliquoted into 10-mL bottles and stored at -70 #{176}C.
From homogenization to storage, every step in this 10-h process was carried out without interruption.
The following day, frozen cytosol fractions were lyophi- Reconstitution of control lyophilized powder. On the day of the experiment, the lyophilized control was reconstituted in 2 mL of glycerol/water (10/90 by vol), mixed, and left on ice until used as a control in assays of both ER and PR.
Methods of Analysis
Sucrose density-gradient method: Linear gradients of sucrose (100-300 g/L) were prepared the day before and equilibrated at 4 #{176}C overnight. Two 250-L samples of cythsol were incubated with 1.0 pmol of radioactive estradiol ([2,4,6,7-3H]estradiol-1713) for 4 hat 4 #{176}C. One of the samples was incubated with 100 pmol of diethylstilbestrol (DES) for 15 mm before the tritiated estradiol was added.
Charcoal pellets used to separate the free from bound radiolabeled estradiol were prepared as follows: 1 mL of a suspension containing 2. the supernate for radioactivity, using Bray's scintillation cocktail. This method is especially useful when the amount of the tumor tissue for analysis is limited and when multiple receptor determinations are needed on a single specimen.
Progesterone receptors were quantified similarly
(3).
R5020 (17,21-dimethyl-19-nor-pregna-4,9-diene-3,10-one) and radiolabelled R5020 obtained from New England Nuclear (Boston, MA 02118) were used for the PR assays.
Results
Stability of human uterus powder (HUP) was studied for ER and PR concentrations for several months. To analyze ER and PR, the dextran-coated charcoal assay was our routine procedure, but we used sucrose density-gradient ultracentrifugation and single saturation-dose methods periodically to check the accuracy of the system. Figure 1 shows a Scatchard plot analysis for ER in HUP #1, and Figure 2 shows the results of sucrose density-gradient analysis for both ER and PR. The Scatchard plot confirms the presence of ER (Kd 4.9 x 10 mollL, Ka 2.03 x 1010 L/ mol), and the sucrose density-gradient assay confirms the presence of both 8S and 4S fragments of estrogen receptors.
To prevent loss of receptor activity, the freshly obtained samples were quickly frozen in liquid nitrogen, transported on solid CO2 to the laboratory, and pulverized at liquid nitrogen temperatures. Homogenization was at 0 #{176}C, ultracentrifugation between 2 and 4#{176}C. Scatchard plot analyses on the lyophilized powders showed no loss in receptor activity. After storage of the lyophilized samples at -70 #{176}C HUP #3 was not frozen in liquid nitrogen soon after collection, but the remaining steps in preparing the lyophilized powder were carefully followed as with HUP #1 and 2. Although the sample appeared to be stable for four months, ER and PR activity deteriorated thereafter (Figure 4 ). These findings suggest the possible importance of freezing the uterus in liquid nitrogen.
Discussion
As information regarding ER and PR becomes useful in selecting patients for endocrine treatment, it is critical to set up rigidcontrolsfor ER and PR assays in the laboratory. Several approaches have been previously reported. In England, frozen human breast tissue was used; however, cellularheterogeneity and receptor instability were drawbacks (12). The EORTC group in Holland and Germany used lyophilized tissue powder from human and animal sources (13); the concentration of ER remained stable under various storage
conditions. Similar studies with tissue powder have been instituted by the National Surgical Adjuvant Breast Protocol (NSABP) and the Cancer and Leukemia Group B (CALGB) in the United States. These samples 6c require homogenization of the control specimen before use in the assay.
The method we describe for preparing a homogenous lyophilized specimen derived from human uterus requires only one simple step of reconstituting the lyophilized control specimen with water. The homogeneity of the receptors is maintained for a considerable period-as long as 20 months in quickly frozen, freshly collected human uterine tissue. Using such controls would greatly improve the quality of estrogen and progesterone receptor assays.
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